Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 30Neoplasm Metastasis 4Advanced Breast Cancer 4Triple Negative Breast Neoplasms 3Polycystic Ovary Syndrome 3Neoplasms 3Endometrial Neoplasms 3Prostatic Neoplasms 2Ovarian Neoplasms 2Infertility 2Carcinoma, Intraductal, Noninfiltrating 2Breast Neoplasms, Male 2Uterine Cervical Neoplasms 1Unilateral Breast Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Small Cell Lung Carcinoma 1Sexual Dysfunctions, Psychological 1Recurrence 1Pathologic Complete Response 1Neoplasms by Site 1Leiomyoma 1Hereditary Sensory and Autonomic Neuropathies 1Hemangiosarcoma 1Head and Neck Neoplasms 1HR+/HER2- Breast Cancer 1HER2 Negative Breast Cancer 1Carcinoma, Non-Small-Cell Lung 1Carcinoma, Ductal 1Breast Neoplasm Female 1Breast Diseases 1

Interventions

Surgical Procedures, Operative 1Specimen Handling 1Letrozole 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Carcinoma, Ductal × Letrozole × 30 days × Clear all
NCT05183828 2026-06-04

Effect of HSD3B1 (1245C) Gene Mutation on Treatment of Stage I-III Breast Cancer

University of Washington

Phase 4 Terminated
62 enrolled

Carcinoma, Ductal

Data powered by HemOnc (CC BY 4.0) Colophon âš¡